Skip to main content
. 2018 Oct 24;35(1):1–14. doi: 10.1007/s10565-018-9446-9

Fig. 3.

Fig. 3

Integrated surface of the user interface of the developed platform for validation of gene expression-based biomarkers. Affymetrix chip and RNA-Seq data have been processed and annotated with clinicopathological information to provide a readily accessible and versatile tool for validation. For malignant melanoma, the TCGA data was analyzed and publicly released for non-informaticians